IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 147 filers reported holding IMMUNITYBIO INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15 | -92.5% | 8,883 | -91.9% | 0.00% | – |
| Q1 2023 | $199 | +1890.0% | 109,766 | +5415.9% | 0.00% | – |
| Q4 2022 | $10 | -100.0% | 1,990 | -96.4% | 0.00% | – |
| Q3 2022 | $274,000 | +81.5% | 55,252 | +35.2% | 0.00% | – |
| Q2 2022 | $151,000 | +11.9% | 40,852 | +69.3% | 0.00% | – |
| Q1 2022 | $135,000 | -72.4% | 24,136 | -70.0% | 0.00% | – |
| Q4 2021 | $489,000 | +940.4% | 80,448 | +2308.6% | 0.00% | – |
| Q3 2021 | $47,000 | +14.6% | 3,340 | +15.5% | 0.00% | – |
| Q2 2021 | $41,000 | -95.6% | 2,891 | -92.7% | 0.00% | -100.0% |
| Q1 2021 | $936,000 | – | 39,460 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Winning Points Advisors, LLC | 236,956 | $879,000 | 0.97% |
| HARBOURVEST PARTNERS LLC | 335,709 | $1,249,000 | 0.41% |
| ALLEN HOLDING INC /NY | 687,571 | $2,558,000 | 0.37% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $359,000 | 0.15% |
| SHEETS SMITH WEALTH MANAGEMENT | 207,926 | $773,000 | 0.13% |
| Corton Capital Inc. | 29,032 | $108,000 | 0.10% |
| Clearwater Capital Advisors, LLC | 185,311 | $689,000 | 0.09% |
| Delphia (USA) Inc. | 31,709 | $118,000 | 0.08% |
| Virtus ETF Advisers LLC | 34,799 | $129,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 84,884 | $316,000 | 0.05% |